Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px
Organisation › Details

Medicxi Ventures (formerly Index Ventures Life Sciences)

Medicxi is based in London, Geneva and Jersey. The firm's mission is to invest across the full healthcare continuum. Medicxi was established by the former Index Ventures life sciences team and continues to manage the legacy life sciences portfolio of Index Ventures. Medicxi has also recently launched two new funds - Medicxi Ventures 1 (MV1) and Medicxi Growth 1 (MG1) – that focus respectively on earlystage and late-stage investments in life sciences. GSK, Johnson & Johnson and Novartis, three of the world’s largest pharmaceutical companies back Medicxi along with Verily, an Alphabet company. These companies, whilst participating in the SABs of the Medicxi funds, do not receive any preferential rights to the portfolio companies. Medicxi’s team has been investing in life sciences for over 20 years and has backed many successful companies, including Genmab (NASDAQ Copenhagen: GEN), PanGenetics (sold to AbbVie), Micromet (sold to Amgen), Molecular Partners (SWX: MOLN), XO1 (sold to Janssen), Minerva Neurosciences (NASDAQ: NERV), Padlock Therapeutics (sold to Bristol-Myers Squibb) and Impact Biomedicines (sold to Celgene). *

 

Period Start 2016-02-02 established (s-off)
  Predecessor Index Ventures
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Persons Person de Rubertis, Francesco (Medecxi Ventures 201602 General Partner before Index Ventures 200708 General Partner)
  Person 2 Grainger, David (Medixci Ventures 201602– General Partner before Index Ventures 2012– + Funxional Therapeutics)
     
  Street 3 Burlington Gardens
  City W1S 3EP London
  Tel +44-20-7154-2020
    Address record changed: 2020-01-23
     
Basic data Employees n. a.
     
    * Document for �About Section�: Yukin Therapeutics S.A.S.. (6/4/19). "Press Release: Yukin Therapeutics Raises €3.3 million to Develop New Cancer Treatments". Sophia Antipolis.
     
   
Record changed: 2020-01-09

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Medicxi Ventures (formerly Index Ventures Life Sciences)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BIO-Europe Spring 2020 Paris BEU2020 650x75




» top